Loiseau, P.M.

Publications

P290

ChemMedChem. 2025, 20, e202400862.

Investigating the C2 modulation of the imidazo[1,2-a]pyrazine-based hit compound CTN1122: synthesis, in vitro antileishmanial activity, cytotoxicity and casein kinase 1 inhibition.

Tisseur, L. Cojean, S. Gassama, K. Logé, C. Pagniez, F. Cavé, C. Bernadat, G. Loiseau, P.M. Bach, S. Thiéfaine, J. Picot, C. Tomasoni, C. Leclercq, O. Baratte, B. Robert, T. Le Pape, P. Rachidi, N. Bazin, M.-A. Marchand, P.

https://doi.org/10.1002/cmdc.202400862

P231

Eur. J. Med. Chem. 2021, 210, 112956.

In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition.

Bazin, M.-A. Cojean, S. Pagniez, F. Bernadat, G. Cavé, C. Ourliac-Garnier, I. Nourrisson, M.-R. Morgado, C. Picot, C. Leclercq, O. Baratte, B. Robert, T. Späth, G.F. Rachidi, N. Bach, S. Loiseau, P.M. Le Pape, P. Marchand, P.

doi: 10.1016/j.ejmech.2020.112956